Avoro Capital Advisors LLC Q2 2022 Filing
Filed August 15, 2022
Portfolio Value
$5.1T
Holdings
40
Report Date
Q2 2022
Filing Type
13F-HR
All Holdings (40 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | UTHUNITED THERAPEUTICS CORP | 2,970,000 | $699.9B | 13.83% | |
| 2 | ARGXARGENX SE | 1,265,555 | $479.5B | 9.48% | |
| 3 | APLSAPELLIS PHARMACEUTICALS INC | 9,805,000 | $443.4B | 8.76% | |
| 4 | HZNPHORIZON THERAPEUTICS PLC | 5,000,000 | $398.8B | 7.88% | |
| 5 | MRTXEURMIRATI THERAPEUTICS INC | 5,550,555 | $372.6B | 7.36% | |
| 6 | AM6AMICUS THERAPEUTICS INC | 26,800,000 | $287.8B | 5.69% | |
| 7 | BMRNBIOMARIN PHARMACEUTICAL INC | 3,284,000 | $272.1B | 5.38% | |
| 8 | SGENUSDSEAGEN INC | 1,525,000 | $269.8B | 5.33% | |
| 9 | SRPTSAREPTA THERAPEUTICS INC | 3,390,000 | $254.1B | 5.02% | |
| 10 | ASNDASCENDIS PHARMA | 2,275,000 | $211.5B | 4.18% | |
| 11 | ALNYALNYLAM PHARMACEUTICALS INC | 1,360,000 | $198.4B | 3.92% | |
| 12 | XENEXENON PHARMACEUTICALS INC | 4,900,000 | $149.1B | 2.95% | |
| 13 | MDGLMADRIGAL PHARMACEUTICALS INC | 1,535,000 | $109.9B | 2.17% | |
| 14 | IOVAIOVANCE BIOTHERAPEUTICS INC | 9,220,000 | $101.8B | 2.01% | |
| 15 | KURAKURA ONCOLOGY INC | 4,800,000 | $88.0B | 1.74% | |
| 16 | KRYSKRYSTAL BIOTECH INC | 1,075,000 | $70.6B | 1.39% | |
| 17 | BCRXBIOCRYST PHARMACEUTICALS INC | 6,500,000 | $68.8B | 1.36% | |
| 18 | OPHTEURIVERIC BIO INC | 7,120,000 | $68.5B | 1.35% | |
| 19 | XBISPDR SERIES TRUST - S&P BIOTECH | 900,000 | $66.8B | 1.32% | |
| 20 | RAREULTRAGENYX PHARMACEUTICAL INC | 750,000 | $44.7B | 0.88% | |
| 21 | PMVPPMV PHARMACEUTICALS INC | 3,100,000 | $44.2B | 0.87% | |
| 22 | SNDXSYNDAX PHARMACEUTICALS INC | 2,222,222 | $42.8B | 0.84% | |
| 23 | —MERSANA THERAPEUTICS INC | 7,550,000 | $34.9B | 0.69% | |
| 24 | MNKDMANNKIND CORP | 9,100,000 | $34.7B | 0.69% | |
| 25 | GLUEMONTE ROSA THERAPEUTICS INC | 3,311,536 | $32.0B | 0.63% | |
| 26 | DSGNDESIGN THERAPEUTICS INC | 2,222,222 | $31.1B | 0.61% | |
| 27 | CBAYUSDCYMABAY THERAPEUTICS INC | 10,300,000 | $30.4B | 0.60% | |
| 28 | KYMRKYMERA THERAPEUTICS INC | 1,260,000 | $24.8B | 0.49% | |
| 29 | WHWKAADI BIOSCIENCES INC | 1,829,402 | $22.5B | 0.45% | |
| 30 | RNAAVIDITY BIOSCIENCES INC | 1,300,000 | $18.9B | 0.37% | |
| 31 | —DICE THERAPEUTICS INC | 1,075,000 | $16.7B | 0.33% | |
| 32 | MRNS*MARINUS PHARMACEUTICALS INC | 3,150,000 | $15.2B | 0.30% | |
| 33 | NUVLNUVALENT INC | 1,049,471 | $14.2B | 0.28% | |
| 34 | IOBTIO BIOTECH INC | 2,055,883 | $9.6B | 0.19% | |
| 35 | AMRNAMARIN CORP PLC | 6,000,000 | $8.9B | 0.18% | |
| 36 | TNGXTANGO THERAPEUTICS INC | 1,550,000 | $7.0B | 0.14% | |
| 37 | FRXFENNEC PHARMACEUTICALS INC | 1,200,000 | $6.8B | 0.13% | |
| 38 | RLAYRELAY THERAPEUTICS INC | 400,000 | $6.7B | 0.13% | |
| 39 | —APPLIED MOLECULAR TRANS INC | 1,030,000 | $3.0B | 0.06% | |
| 40 | GNCAQGENOCEA BIOSCIENCES INC | 5,084,184 | $86.0M | 0.00% |